ClinicalTrials HQ

Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older

Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older

Active, not recruiting · NCT04974216 · Registry updated 2026-06-04
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Olderdiffuse large B-cell lymphomaActive, not recruitingPhase 22026-06-04NCT04974216

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
The Lymphoma Academic Research Organisation20

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
APHP - Hôpital Saint LouisParisFrance5
Besancon University Hospital CenterBesançonFrance1
Centre Henri BecquerelRouenFrance71
Centre Hospitalier D AvignonAvignonFrance1
Centre Hospitalier de La Cote BasqueBayonneFrance2
Centre Hospitalier Departemental VendeeLa Roche-sur-YonFrance1
Centre Hospitalier Sud FrancilienCorbeil-EssonnesFrance13
CH Saint Vincent de PaulLilleFrance1
CHRU de LILLE - Claude HuriezLilleFrance3
CHRU Mont GodinneYvoirBelgium2
CHU BraboisVandœuvre-lès-NancyFrance2
CHU de Bordeaux - Hôpital Haut LévêqueBordeauxFrance2
Chu de Limoges - Hopital DupuytrenLimogesFrance5
CHU de LiègeLiègeBelgium9
CHU de Nantes - Hôtel DieuNantesFrance10
CHU HeloraLa LouvièreBelgium2
Clinique Universitaire Saint LUCBrusselsBelgium3
Grand Hopital de CharleroiCharleroiBelgium2
Institut Bergonié - BordeauxBordeauxFrance1
Institut de Cancérologie de la Loire Lucien NeuwirthSaint-Priest-en-JarezFrance2